Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biogen
4
×
bristol-myers squibb
4
×
clinical trials
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
alzheimer's disease
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
nonalcoholic steatohepatitis
abbvie
aducanumab
affordable care act
biotech
cancer
cancer immunotherapy
cerevel therapeutics
deals
drugs
What
bio
drug
4
×
roundup
alzheimer’s
biogen’s
nash
news
week
aducanumab
advanced
amyloid
angst
annual
approval
arrival
assessed
attention
award
bagged
billions
biogen
biopharmaceutical
biotech
brammer
cancer
communities
companies
conference
convo
data
death
decades
dems
earlier
effects
esmo
europe
failure
failures
felt
Language
unset
Current search:
biogen
×
drug
×
" bristol-myers squibb "
×
@xconomy.com
4 years ago
Bio Roundup: Award Winners, Lung Data, Dems on Drug Pricing & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: Amyloid Angst, NASH News, Brammer Bagged & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More
